Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/01/016998
CTRI/2019/01/016998
Not Applicable
未知

ovel technique for management of primary congenital glaucoma

Ashraf Bori0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: O- Medical and Surgical

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and Surgical
Sponsor
Ashraf Bori
Status
Not Applicable
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Ashraf Bori

Eligibility Criteria

Inclusion Criteria

  • •50 patients with primary congenital glaucoma

Exclusion Criteria

  • •Any eye with previous ocular surgery

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
A study to compare various treatment methods for the miscarriage during the first fourteen weeks of pregnancyFirst trimester miscarriage
SLCTR/2014/029De Soysa Hospital for Women180
Active, not recruiting
Not Applicable
Traitement in utero de l’infection congénitale à cytomegalovirus (CMV) par valaciclovir : essai prospectif randomisé contre placebo - CYMEVA'infection par cytomégalovirus chez la femme enceinte.MedDRA version: 8.1Level: PTClassification code 10011828Term: L'Infection à Cytomégalovirus
EUCTR2007-005525-29-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Recruiting
Not Applicable
Prospective study on the treatment of congenital vaginal agenesis or vaginal hypoplasia - genital reconstruction, gynecological and urological aspects, psychosexual and social aspects and quality of lifeDisorders of sex developmenthermaphroditismintersex100386081001061210029903
NL-OMON36303Erasmus MC, Universitair Medisch Centrum Rotterdam545
Completed
Not Applicable
PAH-CHD predominantly Lt-Rt shunt with borderline PVR and ESData of outcomes in patients who had PAH-CHD (confirmed by dignostic cardiac catheterization) with borderline pulmonary vascular resistance (PVR) and recieved directed targeted therapy prior to surgicPulmonary arterial hypertension, Congenital heart disease, treat and repair
TCTR20200420004Faculty of Medicine432
Active, not recruiting
Phase 1
Prenatal treatment of congenital cytomegalovirus infection with letermovir randomized against valaciclovir (CYMEVAL III)
CTIS2024-512869-14-00Assistance Publique Hopitaux De Paris46